ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Brian Ward from Aroa Biosurgery"
Episode Synopsis
This week on Lunch Money, Brooke Roberts (Sharesies' co-founder) and Alice Rountree (Sharesies' Financial Analyst) chat to Brian Ward, CEO of ASX-listed company Aroa Biosurgery—a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products. Brian takes us through Aroa's business model, and reflects on Aroa's journey to becoming an ASX-listed company.See omnystudio.com/listener for privacy information.
More episodes of the podcast Shared Lunch
Best bite: How Briscoes chose where to win
24/12/2025
What’s next for Sharesies in 2026?
21/12/2025
2025’s big lessons for investors
17/12/2025
The Kiwi company powering global cinemas
10/12/2025
Inside an Aussie infrastructure giant
03/12/2025
Can you spend your way to wealth?
26/11/2025
Bite: Gold. Still a safe haven?
23/11/2025
In God we trust